- Home
- HSDT vs ISPC Comparison
HSDT vs ISPC Comparison
Compare HSDT & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSDT
- ISPC
- Stock Information
- Founded
- HSDT N/A
- ISPC 2009
- Country
- HSDT United States
- ISPC United States
- Employees
- HSDT 21
- ISPC N/A
- Industry
- HSDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ISPC Precision Instruments
- Sector
- HSDT Health Care
- ISPC Health Care
- Exchange
- HSDT Nasdaq
- ISPC Nasdaq
- Market Cap
- HSDT 4.2M
- ISPC 4.6M
- IPO Year
- HSDT N/A
- ISPC 2021
- Fundamental
- Price
- HSDT $5.94
- ISPC $1.16
- Analyst Decision
- HSDT Hold
- ISPC
- Analyst Count
- HSDT 1
- ISPC 0
- Target Price
- HSDT N/A
- ISPC N/A
- AVG Volume (30 Days)
- HSDT 993.8K
- ISPC 504.7K
- Earning Date
- HSDT 08-14-2025
- ISPC 08-14-2025
- Dividend Yield
- HSDT N/A
- ISPC N/A
- EPS Growth
- HSDT N/A
- ISPC N/A
- EPS
- HSDT N/A
- ISPC N/A
- Revenue
- HSDT $295,000.00
- ISPC $5,908,088.00
- Revenue This Year
- HSDT N/A
- ISPC $35.93
- Revenue Next Year
- HSDT $75.13
- ISPC N/A
- P/E Ratio
- HSDT N/A
- ISPC N/A
- Revenue Growth
- HSDT N/A
- ISPC N/A
- 52 Week Low
- HSDT $5.37
- ISPC $0.86
- 52 Week High
- HSDT $1,200.00
- ISPC $8.30
- Technical
- Relative Strength Index (RSI)
- HSDT 24.77
- ISPC 48.15
- Support Level
- HSDT $5.75
- ISPC $1.13
- Resistance Level
- HSDT $6.04
- ISPC $1.85
- Average True Range (ATR)
- HSDT 0.43
- ISPC 0.20
- MACD
- HSDT 2.01
- ISPC -0.03
- Stochastic Oscillator
- HSDT 22.88
- ISPC 18.29
About HSDT Helius Medical Technologies Inc. (DE)
Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS) is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.